Avidity Biosciences Inc (RNA)
29.51
+0.79
(+2.75%)
USD |
NASDAQ |
May 17, 16:00
29.30
-0.21
(-0.71%)
After-Hours: 20:00
Avidity Biosciences Stock Buybacks (Quarterly): -244.24M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -244.24M |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | -38.11M |
March 31, 2023 | -22.44M |
December 31, 2022 | -243.08M |
September 30, 2022 | -39.32M |
June 30, 2022 | -38.28M |
March 31, 2022 | -24.10M |
December 31, 2021 | -9.077M |
September 30, 2021 | -165.60M |
Date | Value |
---|---|
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 24.03M |
September 30, 2020 | 0.00 |
June 30, 2020 | -298.08M |
March 31, 2020 | |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.039M |
March 31, 2019 | -0.039M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-298.08M
Minimum
Jun 2020
24.03M
Maximum
Dec 2020
-57.80M
Average
-9.077M
Median
Dec 2021
Stock Buybacks (Quarterly) Benchmarks
Catalyst Pharmaceuticals Inc | -140.70M |
Vertex Pharmaceuticals Inc | 364.70M |
Codexis Inc | 0.00 |
Sarepta Therapeutics Inc | -- |
PTC Therapeutics Inc | -- |